Showing 19,181 - 19,200 results of 102,951 for search '(( a web decrease ) OR ( 5 ((point decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.39s Refine Results
  1. 19181

    Table_2_Clinical Efficacy, Safety and Tolerability of a New Subcutaneous Immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the Treatment of Patients With Primary Immunodeficiencies.do... by Roger H. Kobayashi (6291587)

    Published 2019
    “…Octanorm (marketed as cutaquig® in USA and Canada) is a new 16.5% solution of human SCIG, manufactured by a process based on that of the intravenous preparation (IVIG) octagam®.…”
  2. 19182

    Table_2_Clinical Efficacy, Safety and Tolerability of a New Subcutaneous Immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the Treatment of Patients With Primary Immunodeficiencies.do... by Roger H. Kobayashi (6291587)

    Published 2022
    “…Octanorm (marketed as cutaquig® in USA and Canada) is a new 16.5% solution of human SCIG, manufactured by a process based on that of the intravenous preparation (IVIG) octagam®.…”
  3. 19183

    Table_1_Clinical Efficacy, Safety and Tolerability of a New Subcutaneous Immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the Treatment of Patients With Primary Immunodeficiencies.do... by Roger H. Kobayashi (6291587)

    Published 2022
    “…Octanorm (marketed as cutaquig® in USA and Canada) is a new 16.5% solution of human SCIG, manufactured by a process based on that of the intravenous preparation (IVIG) octagam®.…”
  4. 19184
  5. 19185
  6. 19186

    Loss of layer V pyramidal neurons of motor cortex. by Paolo d’Errico (494029)

    Published 2013
    “…Values are expressed as mean ± SEM. Scale bars: 5 mm in A; 50 µm in C.</p>…”
  7. 19187
  8. 19188
  9. 19189

    AGAPP: efficacy of first-line cisplatin, 5-fluorouracil with afatinib in inoperable gastric and gastroesophageal junction carcinomas. A Hellenic Cooperative Oncology Group study by George Zarkavelis (10817434)

    Published 2021
    “…The ORR in the per protocol population (PP) was 42.9%. Within a median follow-up of 56 months, the median PFS and OS in the ITT population was 5.0 and 8.7 months, respectively. …”
  10. 19190

    Table 1_Multi-omics-based phenotyping of AFG3L2-mutant lymphoblasts determines key factors of a pathophysiological interplay between mitochondrial vulnerability and neurodegenerati... by Menekse Oeztuerk (20756606)

    Published 2025
    “…Mutations in AFG3L2 are implicated in a spectrum of diseases, including spinocerebellar ataxia type 28 (SCA28) and spastic ataxia 5 (SPAX5), as well as other systemic conditions. …”
  11. 19191

    Image 1_Multi-omics-based phenotyping of AFG3L2-mutant lymphoblasts determines key factors of a pathophysiological interplay between mitochondrial vulnerability and neurodegenerati... by Menekse Oeztuerk (20756606)

    Published 2025
    “…Mutations in AFG3L2 are implicated in a spectrum of diseases, including spinocerebellar ataxia type 28 (SCA28) and spastic ataxia 5 (SPAX5), as well as other systemic conditions. …”
  12. 19192

    Variable Kinetic Isotope Effect Reveals a Multistep Pathway for Protonolysis of a Pt–Me Bond by Irving D. Rettig (14117340)

    Published 2022
    “…This concentration-dependent KIE suggests a multistep reaction mechanism, eliminating the need to invoke proton tunneling. …”
  13. 19193
  14. 19194
  15. 19195

    HuNoV infection slows down intestinal transit. by Arno Cuvry (7405604)

    Published 2024
    “…<p><b>A)</b> Decrease of fluorescent signal over 4 hours in 5-dpf zebrafish larvae. …”
  16. 19196

    Table_5_Depletion of tet2 results in age-dependent changes in DNA methylation and gene expression in a zebrafish model of myelodysplastic syndrome.xlsx by Yaseswini Neelamraju (4509259)

    Published 2023
    “…The gene encoding ten-eleven translocation 2 (tet2), a dioxygenase enzyme that catalyzes the conversion of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine, is a recurrently mutated tumor suppressor gene in MDS and other myeloid malignancies. …”
  17. 19197
  18. 19198

    <i>C. burnetii</i> utilizes α<sub>V</sub>β<sub>3</sub> integrin for uptake in a cholesterol-dependent manner. by Stacey D. Gilk (208034)

    Published 2013
    “…When +cholesterol cells were pre-incubated with vitronectin, the major ligand for a α<sub>V</sub>β<sub>3</sub> integrin, <i>C. burnetii</i> entry decreased by 66% (p = 0.001) and 71% (p<0.0001) as compared to pre-incubation with fibronectin or BSA, respectively. …”
  19. 19199
  20. 19200

    Fluid accumulation studies. by Moumita Mondal (632557)

    Published 2014
    “…For fluid accumulation studies 5 days old infant mice were infected with 100 µl of 1×10<sup>6</sup> CFU/ml of wild type <i>V. cholerae</i>, Δ<i>chiA2</i> mutant, and the complemented strain. …”